New cell therapy shows potential in treating advanced blood disorder
News
CatalYm shows potential of visugromab for treating cachexia
New findings presented at international SCWD conference
Imfinzi receives NICE recommendation for lung cancer treatment
Trial results lead to new treatment option for lung cancer
Poolbeg Pharma presents positive results for POLB 001
promising pre-clinical data on preventing cytokine release syndrome
Teva’s Ajovy shows positive results in preventing pediatric migraines
Phase 3 trial indicates significant efficacy and safety for children and adolescents
NICE endorses Neuraxpharm’s ublituximab for treating MS
New antibody therapy shows promise in managing condition
Antag Therapeutics secures €80 million in weight loss therapy financing
Versant Ventures leads investment round to advance drug
Everest therapy shows promise in nephropathy trial
Data highlights effectiveness of EVER001 in treating pMN
KIMMTRAK recommended for funding by NICE for uveal melanoma patients
Immunocore has announced that Kimmtrak (tebentafusp) has been recommended for funding in England by the National...
Orbit Discovery and Evergreen Theragnostics expand research collaboration
Partnership aims to develop new radiopharmaceuticals for cancer treatment
OGT launches enhanced genetic profiling panel for CLL
New SureSeq CLL + CNV V3 panel improves understanding of CLL
Pharma giants vie for oral GLP-1R approval
Race to create first oral drug for obesity intensifies
New injection offers hope for asthma and COPD attacks
Injection significantly reduces need for further treatment
UK grants promising innovative medicine status to CIDP drug
Therapy for autoimmune disorder shows potential
Cytomos raises $5m to scale up cell analysis technology production
The biotech will use the funding to drive sales of its first commercial product
